Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women

By Ylikorkala O.   Evio S.   Valimaki M.   Tiitinen A.  

Fertility and Sterility, Vol. 80, Iss. 3, 2003-09 ,pp. : 541-545

Elsevier

Access to resources Recommend Favorite

Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels

By Serin I.S.   Ozcelik B.   Basbug M.   Aygen E.   Kula M.   Erez R.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 99, Iss. 2, 2001-12 ,pp. : 222-225

Elsevier

Access to resources Recommend Favorite

Hormone therapy use after the Women's Health Initiative

By MacLennan AH   Taylor AW   Wilson DH  

Climacteric, Vol. 7, Iss. 2, 2004-06 ,pp. : 138-142

Informa Healthcare

Access to resources Recommend Favorite

Health risks after cessation of postmenopausal hormone therapy

By Pines Amos   Sturdee David   Birkhauser Martin  

Climacteric, Vol. 11, Iss. 3, 2008-01 ,pp. : 179-180

Informa Healthcare

Access to resources Recommend Favorite

Adverse mood effects during postmenopausal hormone treatment in relation to personality traits

By Bjorn I.   Backstrom T.   Lalos A.   Sundstrom-Poromaa I.  

Climacteric, Vol. 9, Iss. 4, 2006-08 ,pp. : 290-297

Informa Healthcare

Access to resources Recommend Favorite